[Measurement of plasma pentosidine and the clinical significance in diagnosis of diabetic nephropathies].
Sanaka
Tsutomu
T
Department of Medicine, Daini Hospital Medical Center, Tokyo Women's Medical University.
Hosokawa
Tomoyoshi
T
D001120:Arginine / Q000031:analogs & derivatives* / Q000097:blood; D015415:Biomarkers / Q000097:blood; D003928:Diabetic Nephropathies / Q000175:diagnosis*; D004797:Enzyme-Linked Immunosorbent Assay / Q000379:methods; D005260:Female; D017127:Glycation End Products, Advanced / Q000097:blood*; D006801:Humans; D007676:Kidney Failure, Chronic / Q000175:diagnosis; D008239:Lysine / Q000031:analogs & derivatives* / Q000097:blood; D008297:Male; D018384:Oxidative Stress; D012372:ROC Curve; D011933:Reagent Kits, Diagnostic; D012680:Sensitivity and Specificity
D015415:Biomarkers; D017127:Glycation End Products, Advanced; D011933:Reagent Kits, Diagnostic; D001120:Arginine; C062187:pentosidine; D008239:Lysine